LifeStance Health Group, Inc. (LFST)
USD 6.48
(1.73%)
USD 6.48
(1.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 432.21 Million USD | 17.49% |
| 2022 | 367.86 Million USD | 3818.91% |
| 2021 | 9.38 Million USD | -97.27% |
| 2020 | 343.7 Million USD | 353.24% |
| 2019 | 75.83 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 456.32 Million USD | 5.58% |
| 2024 Q2 | 410.35 Million USD | -10.07% |
| 2023 Q2 | 418.14 Million USD | 2.99% |
| 2023 FY | 432.21 Million USD | 17.49% |
| 2023 Q1 | 406.01 Million USD | 10.37% |
| 2023 Q4 | 432.21 Million USD | -1.97% |
| 2023 Q3 | 440.88 Million USD | 5.44% |
| 2022 Q3 | 121.7 Million USD | 14.09% |
| 2022 FY | 367.86 Million USD | 3818.91% |
| 2022 Q2 | 106.67 Million USD | 68.29% |
| 2022 Q1 | 63.39 Million USD | 491.88% |
| 2022 Q4 | 367.86 Million USD | 202.26% |
| 2021 Q1 | 347.8 Million USD | 1.19% |
| 2021 FY | 9.38 Million USD | -97.27% |
| 2021 Q4 | 10.71 Million USD | 119.59% |
| 2021 Q3 | -54.67 Million USD | 54.1% |
| 2021 Q2 | -119.12 Million USD | -134.25% |
| 2020 Q1 | 3.48 Million USD | 0.0% |
| 2020 Q4 | 343.7 Million USD | 0.0% |
| 2020 FY | 343.7 Million USD | 353.24% |
| 2019 FY | 75.83 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 69.36% |
| Addus HomeCare Corporation | 110.39 Million USD | -291.534% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -383.433% |
| Amedisys, Inc. | 341.35 Million USD | -26.62% |
| American Oncology Network, Inc. | 99.78 Million USD | -333.145% |
| Astrana Health, Inc. | 27.2 Million USD | -1488.628% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 70.299% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 195222.59% |
| biote Corp. | 25.86 Million USD | -1570.795% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -4020.301% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 3754.502% |
| COMPASS Pathways plc | -187.58 Million USD | 330.408% |
| DocGo Inc. | -12.78 Million USD | 3479.606% |
| The Ensign Group, Inc. | 1.36 Billion USD | 68.258% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 4141.309% |
| InnovAge Holding Corp. | 56.08 Million USD | -670.593% |
| Assure Holdings Corp. | 14.68 Million USD | -2843.863% |
| The Joint Corp. | -2.47 Million USD | 17531.941% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 7243.436% |
| ModivCare Inc. | 1.13 Billion USD | 61.996% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -155123.398% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -10558.033% |
| Option Care Health, Inc. | 822.56 Million USD | 47.455% |
| P3 Health Partners Inc. | 83.7 Million USD | -416.346% |
| P3 Health Partners Inc. | 83.7 Million USD | -416.346% |
| The Pennant Group, Inc. | 323.57 Million USD | -33.577% |
| Surgery Partners, Inc. | 2.86 Billion USD | 84.918% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 14355.343% |
| Talkspace, Inc. | -123.9 Million USD | 448.822% |
| Talkspace, Inc. | -123.9 Million USD | 448.822% |
| The Oncology Institute, Inc. | 86.32 Million USD | -400.675% |
| The Oncology Institute, Inc. | 86.32 Million USD | -400.675% |